Product Information
BELBUCA 450 MCG FILM is a brand product labeled by BioDelivery Sciences International Inc, priced at $16.1142 per EA under NDC 59385002460. Its NADAC has been published 470 times since Oct 4, 2017.
FDA first approved this application on Oct 23, 2015.
Strength
450 ug/1
Manufacturer
BioDelivery Sciences International IncNDC
59385002460
Classification
Brand
Dosage Form
FILM, SOLUBLE
Route
BUCCAL
Effective Date
9/23/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA207932FDA Approved
10/23/2015
On Market Since
8/21/2017
Pharmacological Classes
Price Statistics
The NADAC for BELBUCA 450 MCG FILM has been published 470 times since Oct 4, 2017, and over the history we have for it it has risen 69.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.1142 per EA |
|---|---|
| All-time high | $16.1392 (Aug 12, 2026) |
| All-time low | $9.4950 (Jan 17, 2018) |
| 52-week high | $16.1392 |
| 52-week low | $15.3537 |
| Median price | $13.1273 |
| Average price | $13.0163 |
| Largest weekly change | +9.4% (Mar 20, 2019) |
| Weeks tracked | 470 |
| Tracking since | Oct 4, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the buprenorphine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BioDelivery Sciences International Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
buprenorphine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Partial Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BELBUCA 450 MCG FILM?
The current National Average Drug Acquisition Cost (NADAC) for BELBUCA 450 MCG FILM, manufactured by BioDelivery Sciences International Inc, is $16.1142 per EA (NDC 59385002460), effective Sep 30, 2026.
How has the price of BELBUCA 450 MCG FILM changed over time?
Over the history we have for it, the NADAC for BELBUCA 450 MCG FILM has risen 69.0%. It has been tracked across 470 weekly CMS publications since Oct 4, 2017.
What are the highest and lowest recorded NADAC prices for BELBUCA 450 MCG FILM?
Since Oct 4, 2017, the NADAC for BELBUCA 450 MCG FILM has ranged from a low of $9.4950 (Jan 17, 2018) to a high of $16.1392 (Aug 12, 2026), with a median of $13.1273 per EA.
Are there cheaper alternatives to BELBUCA 450 MCG FILM?
No other NADAC-published product currently shares the active ingredient and strength of BELBUCA 450 MCG FILM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BELBUCA 450 MCG FILM?
BELBUCA 450 MCG FILM (NDC 59385002460) is labeled by BioDelivery Sciences International Inc, and CMS classifies it as a brand product.